Characteristics of the 455 patient cohort
| Patient characteristics (n = 455) . | ||
|---|---|---|
| Characteristic . | Value . | |
| Age, median and n (%), y | Median (range) | 63 (21-81) |
| 20-39 | 54 (12%) | |
| 40-59 | 127 (28%) | |
| 60-69 | 170 (37%) | |
| ≥70 | 104 (23%) | |
| Sex, n (%) | Male | 264 (58%) |
| Female | 191 (42%) | |
| Ancestry (broad and subgroup), n (%) | European | 335 (74%) |
| Non-European | 120 (26%) | |
| Northwestern European | 111 (24%) | |
| Mixed European | 99 (22%) | |
| Eastern European | 70 (15%) | |
| Southern European | 51 (11%) | |
| European (NOS) | 4 (1%) | |
| African | 40 (9%) | |
| Non-Black Hispanic | 33 (7%) | |
| Asian | 31 (7%) | |
| Middle Eastern | 10 (2%) | |
| Mixed non-European | 6 (1%) | |
| Diagnosis, n (%) | Acute leukemia | 250 (55%) |
| MDS/MPN | 205 (45%) | |
| Patient characteristics (n = 455) . | ||
|---|---|---|
| Characteristic . | Value . | |
| Age, median and n (%), y | Median (range) | 63 (21-81) |
| 20-39 | 54 (12%) | |
| 40-59 | 127 (28%) | |
| 60-69 | 170 (37%) | |
| ≥70 | 104 (23%) | |
| Sex, n (%) | Male | 264 (58%) |
| Female | 191 (42%) | |
| Ancestry (broad and subgroup), n (%) | European | 335 (74%) |
| Non-European | 120 (26%) | |
| Northwestern European | 111 (24%) | |
| Mixed European | 99 (22%) | |
| Eastern European | 70 (15%) | |
| Southern European | 51 (11%) | |
| European (NOS) | 4 (1%) | |
| African | 40 (9%) | |
| Non-Black Hispanic | 33 (7%) | |
| Asian | 31 (7%) | |
| Middle Eastern | 10 (2%) | |
| Mixed non-European | 6 (1%) | |
| Diagnosis, n (%) | Acute leukemia | 250 (55%) |
| MDS/MPN | 205 (45%) | |
MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; NOS, not otherwise specified.